REGENXBIO's Rollercoaster Ride: A Tale of Two Gene Therapies The Million-Dollar Question: Unpacking the FDA Chief's Gene Therapy Warning A Legal Storm Brews: Sarepta's Groundbreaking Muscular Dystrophy Therapy Faces Renewed Patent Challenge Why Did Regenxbio (RGNX) Shares Take Such a Steep Dive After Hours? Unpacking the Gene Therapy News